{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:45:53Z","timestamp":1780487153290,"version":"3.54.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Outstanding Young Talent Project of the Second Affiliated Hospital of Chongqing Medical University","award":["2014-43"],"award-info":[{"award-number":["2014-43"]}]},{"name":"the Research Projects of the Health Bureau in Chongqing","award":["2010-2-153"],"award-info":[{"award-number":["2010-2-153"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31300137"],"award-info":[{"award-number":["31300137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168582","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T21:11:04Z","timestamp":1483996264000},"page":"e0168582","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis"],"prefix":"10.1371","volume":"12","author":[{"given":"Rongzhong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan Dhruvaraj","family":"Melgiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"L Guariguata","year":"2014","journal-title":"Diabetes research and clinical practice"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"e88078","DOI":"10.1371\/journal.pone.0088078","article-title":"Epidemiology and Mortality of Liver Abscess in End-Stage Renal Disease Dialysis Patients: Taiwan National Cohort Study","volume":"9","author":"C-S Hong","year":"2014","journal-title":"PloS one"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ki.2014.128","article-title":"Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes","volume":"87","author":"ME Molitch","year":"2015","journal-title":"Kidney international"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: a consensus approach","volume":"36","author":"GL Bakris","year":"2000","journal-title":"American journal of kidney diseases"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ki.2013.355","article-title":"Aggressive blood pressure reduction and renin\u2013angiotensin system blockade in chronic kidney disease: time for re-evaluation&quest","volume":"85","author":"PA Sarafidis","year":"2014","journal-title":"Kidney international"},{"issue":"9982","key":"ref6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"SC Palmer","year":"2015","journal-title":"The Lancet"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/dc13-1870","article-title":"Microalbuminuria as a risk predictor in diabetes: the continuing saga","volume":"37","author":"GL Bakris","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","article-title":"Diabetic kidney disease: a report from an ADA consensus conference","volume":"64","author":"KR Tuttle","year":"2014","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Annals of internal medicine"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","article-title":"Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1","volume":"14","author":"JP Jansen","year":"2011","journal-title":"Value in Health"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2","volume":"14","author":"DC Hoaglin","year":"2011","journal-title":"Value in Health"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","article-title":"Diabetic kidney disease with and without albuminuria","volume":"20","author":"RJ MacIsaac","year":"2011","journal-title":"Current opinion in nephrology and hypertension"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjmed.2007.04.023","article-title":"Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis","volume":"120","author":"JZ Li","year":"2007","journal-title":"The American journal of medicine"},{"issue":"7371","key":"ref14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.325.7371.991","article-title":"Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review","volume":"325","author":"TA Furukawa","year":"2002","journal-title":"Bmj"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1875-9114.1998.tb03121.x","article-title":"Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors","volume":"18","author":"CM White","year":"1998","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.jhh.1000991","article-title":"Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension","volume":"14","author":"Z Israili","year":"2000","journal-title":"Journal of Human Hypertension"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(96)90396-3","article-title":"Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass","volume":"78","author":"FH Leenen","year":"1996","journal-title":"The American journal of cardiology"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3317\/jraas.2004.034","article-title":"How do thiazide and thiazide-like diuretics lower blood pressure?","volume":"5","author":"AD Hughes","year":"2004","journal-title":"Journal of Renin-angiotensin-aldosterone system"},{"issue":"20","key":"ref19","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"LF Fried","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"H-H Parving","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9638","key":"ref21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"JF Mann","year":"2008","journal-title":"The Lancet"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"PA James","year":"2014","journal-title":"Jama"},{"key":"ref23","article-title":"Screening, Monitoring, and Management of Chronic Kidney Disease: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians","author":"A Qaseem","year":"2014"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"LA Inker","year":"2014","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12906-016-1228-4","article-title":"Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease","volume":"16","author":"X Yang","year":"2016","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"e0126027","DOI":"10.1371\/journal.pone.0126027","article-title":"Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial","volume":"10","author":"P Li","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of renin\u2013angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"P Vejakama","year":"2012","journal-title":"Diabetologia"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.amjhyper.2006.05.011","article-title":"Effect of Intensive Blood Pressure Control With Valsartan on Urinary Albumin Excretion in Normotensive Patients With Type 2 Diabetes*","volume":"19","author":"RO Estacio","year":"2006","journal-title":"American journal of hypertension"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF02850049","article-title":"Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes","volume":"23","author":"A Atmaca","year":"2006","journal-title":"Advances in therapy"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2337\/diacare.24.5.919","article-title":"Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes","volume":"24","author":"M Bojestig","year":"2001","journal-title":"Diabetes Care"},{"issue":"7274","key":"ref31","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","article-title":"Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study","volume":"321","author":"CE Mogensen","year":"2000","journal-title":"Bmj"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/HJH.0b013e32835a2724","article-title":"Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan\u2013diuretic","volume":"31","author":"M Kojima","year":"2013","journal-title":"Journal of hypertension"},{"issue":"9068","key":"ref33","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(96)10244-0","article-title":"Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria","volume":"349","author":"N Chaturvedi","year":"1997","journal-title":"The Lancet"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2165\/00044011-199700131-00009","article-title":"Effects of amlodipine vs enalapril on microalbuminuria in hypertensive patients with type II diabetes","volume":"13","author":"R Fogari","year":"1997","journal-title":"Clinical drug investigation"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0011-393X(00)80014-4","article-title":"Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus","volume":"61","author":"R Fogari","year":"2000","journal-title":"Current therapeutic research"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0895-7061(02)03017-0","article-title":"Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients","volume":"15","author":"R Fogari","year":"2002","journal-title":"American journal of hypertension"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00228-005-0961-2","article-title":"Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria","volume":"61","author":"R Fogari","year":"2005","journal-title":"European journal of clinical pharmacology"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjhyper.2007.05.012","article-title":"Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria","volume":"20","author":"R Fogari","year":"2007","journal-title":"American journal of hypertension"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14656566.2014.874415","article-title":"Comparative effect of canrenone or hydrochlorothiazide addition to valsartan\/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria","volume":"15","author":"R Fogari","year":"2014","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"18","key":"ref40","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1517\/14656566.2013.848195","article-title":"Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria","volume":"14","author":"R Fogari","year":"2013","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8227(01)00289-3","article-title":"Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM)","volume":"55","author":"S Katayama","year":"2002","journal-title":"Diabetes research and clinical practice"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0272-6386(05)80003-4","article-title":"Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria","volume":"37","author":"G Jerums","year":"2001","journal-title":"American journal of kidney diseases"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2337\/diacare.18.5.690","article-title":"Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients","volume":"18","author":"Z Josefsberg","year":"1995","journal-title":"Diabetes care"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12325-009-0015-8","article-title":"Fixed-dose manidipine\/delapril versus losartan\/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria","volume":"26","author":"O Kohlmann Jr","year":"2009","journal-title":"Advances in therapy"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1523-1755.2000.00224.x","article-title":"Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy","volume":"58","author":"Y Lacourci\u00e8re","year":"2000","journal-title":"Kidney international"},{"key":"ref46","article-title":"Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial","author":"P Li","year":"2015"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000024416.33113.0A","article-title":"Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus a blood pressure\u2013independent effect","volume":"106","author":"G Viberti","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0011-393X(99)90003-6","article-title":"The effects of valsartan and captopril on reducing microalbuminuria in patients with type 2 diabetes mellitus: a placebo-controlled trial","volume":"60","author":"N Muirhead","year":"1999","journal-title":"Current therapeutic research"},{"issue":"6770","key":"ref49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bmj.302.6770.210","article-title":"Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria","volume":"302","year":"1991","journal-title":"BMJ"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s101570200023","article-title":"Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes","volume":"6","author":"T Nakamura","year":"2002","journal-title":"Clinical and experimental nephrology"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.diabres.2005.02.019","article-title":"Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment","volume":"70","author":"M P\u00e9rez-Maraver","year":"2005","journal-title":"Diabetes research and clinical practice"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2796.2001.00821.x","article-title":"Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study","volume":"249","author":"P Poulsen","year":"2001","journal-title":"Journal of internal medicine"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.HYP.0000064943.51878.58","article-title":"Effect of low-dose perindopril\/indapamide on albuminuria in diabetes preterax in albuminuria regression: PREMIER","volume":"41","author":"CE Mogensen","year":"2003","journal-title":"Hypertension"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2337\/diacare.17.5.420","article-title":"Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients","volume":"17","author":"T Sano","year":"1994","journal-title":"Diabetes Care"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10157-003-0227-1","article-title":"Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy","volume":"7","author":"A Sato","year":"2003","journal-title":"Journal of Clinical and Experimental Nephrology"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00580754","article-title":"Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria","volume":"31","author":"C Schnack","year":"1994","journal-title":"Acta diabetologica"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diabres.2005.06.010","article-title":"Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension","volume":"71","author":"AM Sengul","year":"2006","journal-title":"Diabetes research and clinical practice"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1291\/hypres.23.219","article-title":"Effect of Combination Therapy of Angiotensin-Converting Enzyme Inhibitor plus Calcium Channel Blocker on Urinary Albumin Excretion in Hypertensive Microalubuminuric Patients with Type II Diabetes","volume":"23","author":"T SHIGIHARA","year":"2000","journal-title":"Hypertension Research"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2005-1718","article-title":"Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy","volume":"91","author":"K Takebayashi","year":"2006","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/dmrr.255","article-title":"Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria","volume":"18","author":"KC Tan","year":"2002","journal-title":"Diabetes\/metabolism research and reviews"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s592-001-8073-2","article-title":"Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study","volume":"38","author":"N T\u00fct\u00fcnc\u00fc","year":"2001","journal-title":"Acta diabetologica"},{"issue":"9","key":"ref62","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.2337\/db12-1512","article-title":"Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes","volume":"62","author":"EJ Weil","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","article-title":"Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria","volume":"271","author":"G Viberti","year":"1994","journal-title":"Jama"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7326\/0003-4819-139-2-200307150-00008","article-title":"Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial","volume":"139","author":"AA Zandbergen","year":"2003","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"ref65","first-page":"1","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"SP Hozo","year":"2005","journal-title":"BMC medical research methodology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:55:54Z","timestamp":1718992554000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168582"}},"subtitle":[],"editor":[{"given":"Harald","family":"Mischak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168582","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}